CRISPR THERAPEUTICS AG's ticker is and the CUSIP is H17182958. A total of 4 filers reported holding CRISPR THERAPEUTICS AG in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $573,000 | -83.4% | 47 | -79.1% | 0.02% | -83.6% |
Q4 2020 | $3,445,000 | +83.0% | 225 | 0.0% | 0.13% | +12.3% |
Q3 2020 | $1,882,000 | -17.4% | 225 | -27.4% | 0.11% | -26.9% |
Q2 2020 | $2,279,000 | +73.4% | 310 | 0.0% | 0.16% | +43.1% |
Q1 2020 | $1,314,000 | -4.1% | 310 | +37.8% | 0.11% | -8.4% |
Q4 2019 | $1,370,000 | -52.7% | 225 | -68.2% | 0.12% | -55.3% |
Q3 2019 | $2,898,000 | +173.4% | 707 | +214.2% | 0.27% | +177.1% |
Q2 2019 | $1,060,000 | – | 225 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 91,600 | $5,382,000 | 0.05% |
SIMPLEX TRADING, LLC | 176 | $1,034,000 | 0.00% |
JPMORGAN CHASE & CO | 50,000 | $2,938,000 | 0.00% |